Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Pharm Biomed Anal ; 164: 241-248, 2019 Feb 05.
Artigo em Inglês | MEDLINE | ID: mdl-30396051

RESUMO

The urokinase plasminogen activator (uPA) is regarded as the crucial trigger for plasmin generation, which is involved in several diseases especially for neoplasm metastasis. In this study, an efficient approach integrating ultrafiltration, LC/MS, bioassay and in silico docking, was proposed for rapidly detecting uPA ligands from Traditional Chinese Medicines (TCMs). Forty-two TCMs were initially assessed, and as illustrative case studies, Galla Chinensis and Sanguisorbae Radix, which appeared significant inhibitory activities on uPA, were chosen to develpe and verify the strategy. A total of seven uPA ligands were successfully detected and identified. Two of them, pentagalloylglucose and 28-O-ß-d-glucopyranosyl pomolic acid, were demonstrated to be potential inhibitors, with IC50 at 1.639 µM and 37.82 µM repectively. Furthermore, a combinatorial compound library screening combined with in silico docking assay, was revealed that ursolic acid (IC50 = 2.623 µM) was also speculated to be a potent parent structure for inhibition of uPA. This approach offers a multidimensional perspective to discover uPA-binding leading compounds from TCMs or other complex mixtures, which would provide an efficient route for drug discovery.


Assuntos
Descoberta de Drogas/métodos , Medicamentos de Ervas Chinesas/análise , Ensaios Enzimáticos/métodos , Inibidores Enzimáticos/análise , Ativador de Plasminogênio Tipo Uroquinase/antagonistas & inibidores , Cromatografia Líquida de Alta Pressão/instrumentação , Cromatografia Líquida de Alta Pressão/métodos , Descoberta de Drogas/instrumentação , Medicamentos de Ervas Chinesas/química , Medicamentos de Ervas Chinesas/farmacologia , Ensaios Enzimáticos/instrumentação , Inibidores Enzimáticos/química , Inibidores Enzimáticos/farmacologia , Humanos , Concentração Inibidora 50 , Simulação de Acoplamento Molecular , Rhus/química , Sanguisorba/química , Espectrometria de Massas em Tandem/instrumentação , Espectrometria de Massas em Tandem/métodos , Triterpenos/análise , Triterpenos/química , Triterpenos/farmacologia , Ultrafiltração/instrumentação , Ultrafiltração/métodos , Ativador de Plasminogênio Tipo Uroquinase/química , Ácido Ursólico
2.
Eur J Med Chem ; 123: 763-768, 2016 Nov 10.
Artigo em Inglês | MEDLINE | ID: mdl-27537924

RESUMO

Ten novel artemisinin derivatives containing sulfur atoms were designed and synthesized and their structures were confirmed by (1)H NMR, (13)C NMR and HRMS technologies in this study. All compounds were reported for the first time. The in vitro cytotoxicity against PC-3, SGC-7901, A549 and MDA-MB-435s cancer cell lines was evaluated by MTT assay. Compounds 4a and 4f displayed potent antitumor activity against PC-3, SGC-7901 and A549 cells with IC50 ranging from 1.6 to 30.5 µM, which values are compared to that of 5-FU (IC50 from 6.8 to 42.5 µM). Compounds 4a and 4f showed high specificity towards human lung cancer A549 cells compared to normal human hepatic L-02 cells with selectivity index of 16.1 and 50.1 respectively. Our promising findings indicated that the compounds 4a and 4f could stand as potential lead compounds for further investigation.


Assuntos
Antineoplásicos/síntese química , Antineoplásicos/farmacologia , Artemisininas/síntese química , Artemisininas/farmacologia , Enxofre/química , Antineoplásicos/química , Artemisininas/química , Linhagem Celular Tumoral , Técnicas de Química Sintética , Ensaios de Seleção de Medicamentos Antitumorais , Humanos , Relação Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...